Skip to content

Clinical trials

Eye Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Country / region: United States Clear all

173 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20042
20052
20062
20075
20086
20094
20107
20113
20127
20133
20146
20154
20168
20175
20187
201912
202016
202112
202214
202318
20245
20257
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed95
Recruiting25
Terminated23
Active, not recruiting19
Unknown status7
Enrolling by invitation2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)17
Adverum Biotechnologies, Inc.8
Kodiak Sciences Inc7
GenSight Biologics6
LENZ Therapeutics, Inc6
Laboratoires Thea5
Nanoscope Therapeutics Inc.5
Novartis Pharmaceuticals5
University of California, San Francisco4
Duke University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases173
Retinal Diseases59
Retinal Degeneration40
Macular Degeneration36
Vision Disorders25
Glaucoma20
Eye Diseases, Hereditary19
Retinitis Pigmentosa19
Blindness18
Diabetic Retinopathy16

Trials

Showing 26 to 50 of 173. Each trial links to its page on Pharma Observatory.

73 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.